An alpha -Actinin Binding Site of Zyxin Is Essential for Subcellular Zyxin Localization and alpha -Actinin Recruitment*

Matthias ReinhardDagger §, Jürg Zumbrunn, Daniel Jaquemar, Monika KuhnDagger , Ulrich WalterDagger , and Beat Trueb

From the Dagger  Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Versbacher Strasse 5, D-97078 Würzburg, Germany and the  M. E. Müller Institute, University of Bern, P. O. Box 30, CH-3010 Bern, Switzerland

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The LIM domain protein zyxin is a component of adherens type junctions, stress fibers, and highly dynamic membrane areas and appears to be involved in microfilament organization. Chicken zyxin and its human counterpart display less than 60% sequence identity, raising concern about their functional identity. Here, we demonstrate that human zyxin, like the avian protein, specifically interacts with alpha -actinin. Furthermore, we map the interaction site to a motif of approximately 22 amino acids, present in the N-terminal domain of human zyxin. This motif is both necessary and sufficient for alpha -actinin binding, whereas a downstream region, which is related in sequence, appears to be dispensable. A synthetic peptide comprising human zyxin residues 21-42 specifically binds to alpha -actinin in solid phase binding assays. In contrast to full-length zyxin, constructs lacking this motif do not interact with alpha -actinin in blot overlays and fail to recruit alpha -actinin in living cells. When zyxin lacking the alpha -actinin binding site is expressed as a fusion protein with green fluorescent protein, association of the recombinant protein with stress fibers is abolished, and targeting to focal adhesions is grossly impaired. Our results suggest a crucial role for the alpha -actinin-zyxin interaction in subcellular zyxin localization and microfilament organization.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

A panoply of cellular processes, such as cell-cell and cell-matrix adhesion, motility, morphogenesis, growth and differentiation, are largely dependent on the structure and dynamics of the actin-based cytoskeleton and its associated signaling proteins. Elucidation of the mutual interactions between the wide variety of known microfilament-associated proteins has shed light on the underlying organization of the multi-level protein network and also on its linkages e.g. to transmembrane receptors (for a review see Ref. 1). Due to their involvement in a variety of biological systems, special interest has been devoted to zyxin and the F-actin-binding protein alpha -actinin, two interacting constituents of these supramolecular protein complexes.

alpha -Actinin is a major constituent of diverse actin-based structures, such as stress fibers, focal adhesions, and the peripheral belt of epithelial cells (2, 3). alpha -Actinin is also found in the cortical actin filament webs at the periphery of highly dynamic lamellae (2). The protein forms a rod-shaped antiparallel dimer of approximately 100-kDa subunits, each subunit comprising an N-terminal actin binding domain, four central spectrin-like repeats, and two C-terminal EF-hand motifs (4). Whereas the spectrin-like repeats are thought to be involved in dimerization, the C-terminal domain confers Ca2+ sensitivity on actin binding of different nonmuscle isoforms (5). Like few other cytoskeleton-associated proteins, alpha -actinin constitutes a direct link between the actin cytoskeleton and the cytoplasmic domains of several cell surface receptors, including integrins beta 1 (6), beta 2 (7), and alpha IIbbeta 3 (6), ICAM-11 (8), ICAM-2 (9), L-selectin (10), and the N-methyl-D-aspartate receptor (11). This cytoskeletal connection has been implicated in receptor function and anchorage, cytoskeletal reorganization, and concomitant signaling events (1, 7, 11). Binding of alpha -actinin to PIP2 and phosphatidylinositol 3-kinase, as well as a PIP2-regulated interaction with the Rho effector kinase PKN (12) and vinculin (13) are also consistent with functional roles of alpha -actinin in signal transduction pathways and cytoskeletal organization (5). alpha -Actinin is intimately linked with microfilamentous structures (5) not only by its actin cross-linking activity but also by its interaction with the cell-cell adherens junction protein alpha -catenin, different cysteine-rich proteins (CRPs) (14-17) and zyxin (18). Due to the substantial overlap in subcellular distribution and the emerging functions of zyxin in actin filament regulation, the alpha -actinin-zyxin interaction has gained special interest.

Zyxin was originally identified in chicken fibroblasts as a protein associated with focal adhesions, stress fibers, and cell-cell adherens junctions (19). A human cDNA coding for a protein closely resembling chicken zyxin but with less than 60% sequence identity has been isolated in a subtractive cDNA cloning approach by virtue of its reduced expression in SV40 transformed fibroblasts (20). Independently, an equivalent cDNA has been cloned from an umbilical vein endothelial cell library (21). Zyxin is composed of an extended N-terminal part, which is rich in prolines, and three C-terminal LIM domains. In addition to its sequence similarity, the human protein showed the same subcellular distribution (21, 23) and VASP binding activity (23) as chicken zyxin and hence was proposed to represent the mammalian homologue of avian zyxin (20, 21, 23).

There is a large body of evidence that zyxin plays a major role in the organization of actin filaments in living cells. This evidence originates from its structural and functional relationship with the bacterial protein ActA found at the surface of the intracellular bacterial pathogen Listeria monocytogenes (23, 25, 27, 28). This microorganism invades eukaryotic cells and exploits the host actin-based cytoskeleton to promote its own intracellular motility and cell to cell spread (for a review, see Ref. 29). Detailed studies have revealed that the bacterial protein ActA is both necessary and sufficient for the recruitment of actin filaments and actin-based motility (29). ActA seems to accomplish this function by enhancing the Arp2/3 complex driven nucleation of new actin filaments (30). The N-terminal region of zyxin appears to share some structural and functional similarity with the central and the C-terminal portion of the ActA protein (23, 25, 28). In particular, both zyxin and ActA harbor proline-rich binding sites for their common ligands VASP (23, 25, 27) and Mena (24, 25). The interactions with VASP and Mena are thought to contribute to efficient actin polymerization by recruiting polymerization competent profilactin complexes (24, 31). Hence, zyxin may likewise regulate actin filament organization and thus represent an endogenous ActA analogue in eukaryotic cells (23, 25, 28).

By in vitro binding assays, chicken zyxin has been shown to interact with alpha -actinin (18); the LIM-only proteins CRP1, CRP2, and CRP3/MLP (14-17); and the Ena VASP homology 1 domain of the microfilament organizing proteins VASP and Mena (23-25). The proto-oncogene product Vav binds zyxin in an SH3 domain-dependent manner (26). The in vitro interaction between zyxin and alpha -actinin is of moderate affinity and involves the N-terminal part of alpha -actinin (18), which includes the actin binding domain (4) and also binds to PIP2 (5) and chicken CRP1 (32). Vice versa, the alpha -actinin binding site has only roughly been mapped to the N-terminal region of chicken zyxin (amino acids 1-348; Ref. 15). A similar interaction with alpha -actinin has not yet been established for human zyxin, and also, functional in vivo evidence for a direct alpha -actinin-zyxin linkage is missing.

Therefore, we set out to investigate a putative interaction between human zyxin and alpha -actinin in more detail. In this study, we demonstrate that the human protein binds to alpha -actinin as described for the avian protein. We further localize the interaction site to a motif of about 22 amino acids, present in the zyxin N terminus. Using a synthetic peptide and various deletion constructs, we finally show that this motif, but not a related downstream region, is both necessary and sufficient for zyxin interaction with alpha -actinin in vitro. Furthermore, this alpha -actinin binding site is essential for zyxin-dependent alpha -actinin recruitment in living cells as well as for proper subcellular zyxin localization.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

GST Zyxin Fusion Proteins

Twelve cDNA clones for human zyxin had previously been isolated from a placenta cDNA library (20). The inserts of seven clones with successively truncated 5'-ends (B91, B52, B4, 925, 835, 725, and 225) were selected and subcloned into the EcoRI restriction site of the expression vector pGEX-5X (Amersham Pharmacia Biotech) downstream of the GST gene. Orientation and reading frame of the final constructs were verified by DNA sequencing. Shorter fusion polypeptides were prepared by expression of different restriction fragments in E. coli (BL21). These fragments were prepared from the 5'-end of the full-length zyxin cDNA by partial or complete digestion with the enzymes EcoRI, SmaI, NcoI, MspI, and HaeIII and subsequently ligated in the desired reading frame into the expression vector pGEX-5X.

Mitochondrial Targeting of Zyxin

An FspI fragment comprising bases 55-1318 of the human zyxin cDNA (20) was inserted into the SmaI site of the eukaryotic expression vector pSPL61 (33, 34). The MscI-BamHI fragment of this construct was replaced by sequential ligation with the zyxin MscI-MaeII fragment and an MaeII-BamHI adapter consisting of the complementary oligonucleotides A1 and A2, resulting in the wild type zyxin mitochondrial targeting construct (targZyxinWT).

Construction of Zyxin Deletion Mutants

Deletion of Zyxin Amino Acids 19-41-- Two PCR products were amplified with the wild type mitochondrial targeting construct as a template and the primer pairs U4589/S1L and S1U/L1708, introducing a unique SacII restriction site into each PCR product. Both products were digested with SacII and ligated. The ligation product was then used as a template for PCR amplification with the primer pair U159/L1423. The resulting PCR product was gel purified and cloned into pCRII vector (Invitrogen) and a 267-base pair NcoI-BglII fragment of the corresponding clone was ligated into either NcoI-BglII digested targZyxinWT or wild type GST-zyxin vector.

Deletion of Zyxin Amino Acids 261-283-- Two PCR products amplified from wild type GST-zyxin vector with the primer pairs S1U/S2L and S2U/L1868, respectively, were ligated after NgoMI digestion. With the ligation product as a template and the primers S1U and L1868, a PCR product was amplified, gel purified, and ligated into pCR-Script Amp SK(+) vector (Stratagene). A 589-base pair fragment, which comprises the deletion site corresponding to zyxin amino acids 261-283, was excised with BglII-DraIII and inserted into the BglII-DraIII sites of wild type GST-zyxin, GST-zyxin Delta 19-41, targZyxinWT, and targZyxin Delta 19-41, yielding the corresponding constructs GST-zyxin Delta 261-283, GST-zyxin Delta 19-41/Delta 261-283, targZyxin Delta 261-283, and targZyxin Delta 19-41/Delta 261-283, respectively.

Insertion of Zyxin Amino Acids 262-284 into Position 17-41-- Two complementary synthetic oligonucleotides, OU and OL, were annealed, phosphorylated with T4 polynucleotide kinase, and inserted into the SacII-digested and dephosphorylated targZyxin Delta 19-41 construct. To reduce the background of parental plasmids, the ligated product was digested with SacII prior to transformation into competent DH5alpha cells.

All junctions of different sequence inserts as well as all PCR-amplified regions were verified by DNA sequencing.

Oligonucleotides

The oligonucleotides used were as follows: A1, 5'-CGTGCTCTGTCGGAAGTGCCACACTGCTAGAGCCCAGACG-3'; A2, 5'-GATCCGTCTGGGCTCTAGCAGTGTGGCACTTCCGACAGAGCA-3'; L1423, 5'-ACTTAGGCGCTGGAGCCGGAGATGAG-3'; L1708, 5'-GCTCCTCCACCTCCTTCAGA-3'; L1868, 5'-GCAGGTGAAGCAGGCGATGTG-3'; OU, 5'-CCCTAAGTTTTCTCCAGTGACTCCTAAGTTTACTCCTGTGGCTTCCAAGTTCAGTCCTGGAGC-3'; OL, 5'-TCCAGGACTGAACTTGGAAGCCACAGGAGTAAACTTAGGAGTCACTGGAGAAAACTTAGGGGC-3'; S1L, 5'-TGCACCCCGCGGGAGCCGAGACCGAAACGGAG-3'; S1U, 5'-CGGCTCCCGCGGGTGACAGCGAGCCTCCCCCGGCAC-3'; S2L, 5'-GAAATCTTGCGGCCGCACGCCGGCGATGAGGCTGGGGGCCCTCGG-3'; S2U, 5'-GTTCAGTCCGCCGGCGCCAGGTGGATCTGGGTCACAA-3'; U159, 5'-GAATGAAAGACCCCACCTGTA-3'; U4589, 5'-CGACACGGAAATGTTGAATAC-3'.

Green Fluorescent Protein (GFP) Zyxin Fusion Constructs

The full-length cDNA sequence of human zyxin and three deletion constructs (see above) were amplified by PCR and cloned into the EcoRI-BamHI site of the expression vector pEGFP-C3 (CLONTECH, Palo Alto, CA) downstream of the reporter gene for GFP. The final constructs harbored the zyxin sequence for amino acid residues 1-570 (wild type) or the same sequence with deletions corresponding to amino acid residues 19-41 (GFP-zyxin Delta 19-41), 261-283 (GFP-zyxin Delta 261-283) or 19-41 and 261-283 (GFP-zyxin Delta 19-41/Delta 261-283). The reading frame and the authenticity of the final constructs were verified by DNA sequencing.

Transfection of Cells

pEGFP-C3 plasmids (1 µg/well) were mixed with 100 µl of Opti-MEM 1 (Life Technologies) containing 3 µl of FuGENE-6 reagent (Roche Molecular Biochemicals) and were added to COS-1 cells (ATCC CRL-1650), which had grown to 60% confluence in 6 well plates. Chicken tendon fibroblasts (36) were transfected in a similar way using SuperFect reagent (Qiagen). One to 2 days after transfection, the cells were washed with PBS and inspected at an excitation wave length of 450-490 nm.

PtK2 cells were grown on coverslips in minimum essential medium with Eagle's salts, Glutamax ITM (Life Technologies, Inc.), and 10% fetal calf serum. Cells were transfected with the mitochondrial targeting constructs by the calcium phosphate method, using an overnight incubation with 5 µg of DNA per 3-cm dish. Two days posttransfection, cells were prepared for indirect immunofluorescence microscopy.

Immunofluorescence Microscopy

Immunofluorescence microscopy of formaldehyde fixed cells was done essentially as described (37). The following antibodies were used: rabbit-anti zyxin serum AS83-1 (23), mouse anti-alpha -actinin monoclonal antibody BM 75.2 (Sigma), Oregon Green-labeled goat anti-rabbit antibody (Molecular Probes, Eugene, OR, USA), and Cy3-labeled goat anti-mouse IgG + IgM antibodies (Jackson ImmunoReasearch Laboratories, West Grove, PA). Prior to use the latter antibodies were preadsorbed to rabbit gamma  globulins (Serva, Heidelberg, Germany) immobilized on a Sepharose cartridge.

Immunoblots

Proteins were resolved on SDS-polyacrylamide gels and transferred to nitrocellulose by electroblotting. The blots were incubated with various antibodies or processed for blot overlays. Goat anti-GST antibodies were purchased from Amersham Pharmacia Biotech. The preparation of the anti-human zyxin monoclonal antibody 164ID4 will be described elsewhere.2 A polyclonal antiserum against a synthetic peptide corresponding to human zyxin residues 134-147 was raised in rabbits. Bound antibodies were detected with 125I-labeled sheep anti-mouse antibody (Amersham Pharmacia Biotech) or alkaline phosphatase-conjugated anti-rabbit antibodies (Sigma) followed by development with bromochloroindolyl phosphate and nitroblue tetrazolium substrate.

Blot Overlays

For radiolabeling, alpha -actinin (Sigma A9776) was dialyzed exhaustively against 500 mM NaCl, 50 mM Tris-HCl, pH 7.6, and transferred to a test tube, which had been coated with Iodogen according to the instructions of the manufacturer (Pierce). Carrier-free Na125I (0.5 mCi/200 µg of protein; final volume, 500 µl) was added, and the reaction was allowed to proceed for 10 min on ice, followed by 5 min at room temperature. Radiolabeled protein was separated from nonincorporated iodine by chromatography on Sephadex G-50.

Blot overlays were performed essentially as described (18). Residual protein-binding sites on the nitrocellulose blots were blocked overnight with 0.75% bovine serum albumin in 10 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 0.1% 2-mercaptoethanol, 20 mM HEPES, pH 7.5. The blots were incubated at room temperature on a rocking platform with the radiolabeled probe (5 × 105 cpm/ml). After 4 h, the blots were washed twice with the same buffer and exposed to BioMax MS film (Eastman Kodak Co.).

Solid Phase Binding Assay

For conjugation with peroxidase alpha -actinin was purified from chicken gizzard essentially as described (38), except that phosphocellulose P11 was substituted by fibrous phosphocellulose (Sigma, C-3145), and alpha -actinin was eluted with a linear gradient of 0-500 mM NaCl in equilibration buffer. The protein was >95% pure as judged from SDS-polyacrylamide gel electrophoresis analysis and Coomassie Blue staining. 300 µg of purified alpha -actinin was coupled to 1 mg of preactivated horseradish peroxidase (Pierce) according to the manufacturer's instructions.

Peptides corresponding to human zyxin (20, 21) amino acids 21-42 plus an N-terminal cysteine residue (zyxin21-42) and murine VASP (EMBLTM accession number X98475) amino acids 313-333 including a terminal cysteine (control peptide) were synthesized with acetylated alpha -amino groups and amidated carboxyl termini. The peptides were purified on a VYDAC RP C-8 column to >85% purity and were verified by mass spectral analysis (Genosys Biotechnologies, Pampisford, United Kingdom).

Maleimide activated microtiter plates (Reacti-BindTM, Pierce) and amine binding microtiter plates with an N-oxysuccinimide surface (DNA-BINDTM, Costar) were coated with 50 or 100 µg/ml peptide solution, respectively. After washing and blocking of remaining binding sites 0.5-50 µg/ml peroxidase-labeled alpha -actinin (protein concentration refers to alpha -actinin) was added (triplicates). Bound alpha -actinin-peroxidase conjugate was detected by incubation with o-phenylenediamine peroxidase substrate solution (Sigma). The reaction was stopped by addition of 1 volume of 750 mM HCl. For analysis, background values obtained without peptide coating were subtracted.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Blot Overlays of N-terminal Zyxin Deletion Mutants Reveal a Functional alpha -Actinin Binding Site---A potential interaction of alpha -actinin with human zyxin was investigated in a blot overlay assay. To this end, several cDNA clones for human zyxin were expressed as GST fusion proteins in a prokaryotic expression system. These clones coded for the full-length zyxin sequence and for fragments thereof that were successively truncated from the N terminus. Detection of the expressed fusion proteins with an anti-GST antibody showed that the full-length protein and the truncated forms could successfully be expressed in bacteria, but that a large percentage of the products was degraded into a complex mixture of fragments (not shown). Changing the conditions (i.e. lowering the temperature for expression or utilizing a bacterial strain with minimal endogenous protease activity) did not solve the problem. We therefore transferred the entire mixture of GST fusion proteins to nitrocellulose membranes and probed this blot with radioiodinated alpha -actinin (Fig. 1). Our probe bound to bands of 80 and 36 kDa derived from the full-length construct (amino acids 1-572). A positive reaction with the full-length fusion protein of 110 kDa was visible only when the gel was overloaded and when the blot was exposed for a prolonged period of time (not shown; see also Fig. 6). In contrast, no specific interaction was observed with any of the successively truncated GST-zyxin fusion proteins starting at zyxin amino acid 58 or C-terminal thereof. Some unspecific binding was observed with two bacterial polypeptides of 28 and 33 kDa present in all samples, but these signals disappeared when the fusion proteins were purified on glutathione-Sepharose before being transferred to nitrocellulose. Thus, human zyxin contains at least one major binding site for alpha -actinin, and this site must be located, at least in part, within the first 57 amino acids of the polypeptide.


View larger version (86K):
[in this window]
[in a new window]
 
Fig. 1.   Interaction of alpha -actinin and human zyxin. Different zyxin cDNA constructs were expressed in bacteria as GST fusion proteins, and the proteins were resolved by 10% polyacrylamide gels. After transfer to nitrocellulose, the proteins were probed with radioiodinated alpha -actinin. The cDNA constructs coded for the full-length zyxin sequence (amino acids 1-572) or for fragments that were successively truncated from the N terminus as indicated at the top.

To narrow down this site, we prepared several shorter constructs that covered different regions within the first 51 amino acids of human zyxin and expressed them in bacteria. These fusion peptides proved to be fairly resistant against endogenous proteolysis and could be immobilized on nitrocellulose in virtually intact form after purification on glutathione-Sepharose (Fig. 2). Radiolabeled alpha -actinin bound specifically to the fusion peptides containing residues 1-51 and 1-41, but not to those containing residues 4-18 or 4-27. These results suggest that amino acids 28-41 are part of a major binding site for alpha -actinin.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 2.   Defining the interaction site of human zyxin and alpha -actinin. Short cDNA constructs coding for different regions within the first 51 amino acids of human zyxin were expressed as GST fusion proteins in bacteria. The fusion proteins were purified over glutathione-Sepharose and resolved by 10% polyacrylamide gels. After transfer to nitrocellulose, the proteins were either stained with an antibody against GST (Western blot, left panel) or probed with radioiodinated alpha -actinin (blot overlay, right panel). The constructs coded for the amino acid residues of zyxin as indicated at the top. Rev 27-4 refers to a nonsense fusion peptide encoded by a cDNA sequence complementary to that of 4-27. UTR indicates additional sequence derived from the 5' untranslated region.

In an effort to verify that the protein bound to the zyxin fusion peptides was in fact alpha -actinin, we excised one of the radiolabeled bands from the nitrocellulose membrane and eluted the protein with SDS sample buffer. On a polyacrylamide gel the eluted protein migrated with the same mobility as alpha -actinin, thus proving its identity (Fig. 3).


View larger version (59K):
[in this window]
[in a new window]
 
Fig. 3.   Identification of the protein bound to zyxin as alpha -actinin. The radiolabeled band shown in Fig. 2, lane 1 (right panel) was excised from the nitrocellulose strip and eluted with SDS sample buffer. The eluted protein was run on a 10% polyacrylamide gel (lane 1) next to a standard of radiolabeled alpha -actinin (lane 2).

To investigate whether zyxin sequences that appear to be necessary for the interaction with alpha -actinin per se are capable of alpha -actinin binding, we performed the converse experiment. A peptide corresponding to residues 21-42, preceded by an N-terminal cysteine residue for coupling purposes, was synthesized and coupled to maleimide-activated microtiter plates. In a solid phase binding assay with increasing concentrations of horseradish peroxidase-labeled alpha -actinin added as soluble ligand, this peptide showed a concentration-dependent interaction with alpha -actinin, whereas an unrelated control peptide was negative (Fig. 4). Similar results were also obtained when the peptides were coupled to microtiter plates via their alpha -amino groups instead of terminal cysteine residues (not shown). These results suggest that residues 21-42 of human zyxin represent a functional alpha -actinin binding site.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 4.   Binding of peroxidase-labeled alpha -actinin to a synthetic zyxin peptide (zyxin 21-42) in a solid phase binding assay. Maleimide-activated microtiter plates were coated with the zyxin peptide zyxin21-42 () or a control peptide (open circle ) at 50 µg/ml. After blocking of remaining coupling sites, samples were incubated with increasing concentrations of peroxidase-labeled alpha -actinin. Bound alpha -actinin was quantified by o-phenylenediamine reaction. The values given are means (± S.D.) of triplicates from one out of several experiments with similar results.

The alpha -Actinin Binding Site of Human Zyxin Is Characterized by an Evolutionary Conserved Internal Repeat Structure-- The alpha -actinin binding site of human zyxin contains several prolines and lysines, with the remainder being dominated by aliphatic and aromatic residues (Fig. 5a). It is also conserved in mouse (21) and chicken zyxin (14). In addition, a similar sequence is found in the N terminus of the human LIM domain protein lipoma preferred partner (LPP) (22), which shares limited similarity with human zyxin over its entire sequence.


View larger version (61K):
[in this window]
[in a new window]
 
Fig. 5.   Alignment of the alpha -actinin binding site from human zyxin to homologous sequences from mouse and chicken zyxin and human LPP. a, alignment of the alpha -actinin binding site from human zyxin to zyxin of other species and human LPP. b, dissection into submotifs of the alignment shown in panel a.

A closer analysis of the sequence comprising the alpha -actinin binding site of human zyxin showed that it consists of a 10 amino acids submotif occurring twice in tandem (Fig. 5b). A more detailed search for possible repeat structures revealed a second sequence element within the N-terminal zyxin region that resembles the alpha -actinin binding site identified here. This sequence is located between residues 261 and 284 in human zyxin and is evolutionary conserved in mouse zyxin (21), but not in chicken zyxin (14) or LPP (22). This sequence is characterized by a repeat structure similar to that of the alpha -actinin binding site: it comprises one complete copy of the 10 amino acids submotif (amino acids 261-270 in human zyxin), followed by two truncated copies occurring twice in tandem (amino acids 271-277/278-284 in human zyxin). Each of the truncations lacks the first three amino acids of the 10-amino acid submotif (Fig. 5b).

Our studies so far have identified an N-terminal alpha -actinin binding site in human zyxin and a downstream sequence with remarkable similarity. For a functional comparison of the two sites, three deletion constructs were prepared that lacked either the sequences corresponding to the first site (Delta 19-41), the second site (Delta 261-283), or both sites (Delta 19-41/Delta 261-283). When these constructs were expressed in bacteria as GST fusion proteins and tested in a blot overlay (Fig. 6), an interaction of radiolabeled alpha -actinin was observed with wild type zyxin as well as with zyxin lacking the second site. No interaction was detected with zyxin lacking either the first site or both sites. The first site is therefore indispensable for alpha -actinin binding, whereas there is no evidence for a functional significance of the downstream sequence element.


View larger version (75K):
[in this window]
[in a new window]
 
Fig. 6.   Functional comparison of the alpha -actinin binding site and a related downstream sequence. Different zyxin constructs were expressed as GST fusion proteins in bacteria and resolved on a 6% polyacrylamide gel. The proteins were transferred to nitrocellulose and either stained with a monoclonal antibody against human zyxin (Western blot, left panel) or probed with radioiodinated alpha -actinin (blot overlay, right panel). The cDNA constructs coded for the wild type zyxin sequence (Zyx), the zyxin sequence with deletion of amino acids 19-41 (Zyx Delta 19-41), deletion of amino acids 261-283 (Zyx Delta 261-283), or deletions of amino acids 19-41 and 261-283 (Zyx Delta 19-41/261-283).

The alpha -Actinin Binding Site Is Essential for Proper Subcellular Targeting of Zyxin-- To address possible functions of the alpha -actinin binding site in living cells, the wild type sequence and the three deletion constructs, detailed above, were cloned into a GFP expression vector and transfected into COS cells. With the GFP fluorescence, the subcellular distribution of the GFP fusion proteins was visualized in living cells. The fusion protein synthesized from the wild type sequence was found to be localized at focal contacts and along stress fibers (Fig. 7a). Its distribution was virtually identical to that observed in a parallel experiment by indirect immunofluorescence with an anti-zyxin antibody (not shown; see also Refs. 21 and 23). No difference was noticed with the construct GFP-zyxin Delta 261-283, which encoded GFP-zyxin lacking the downstream site (Fig. 7c). However, after expression of GFP-zyxin lacking the alpha -actinin binding site (GFP-zyxin Delta 19-41) or the first and second site (GFP-zyxin Delta 19-41/Delta 261-283), the majority of the label was diffusely distributed in the cytoplasm (Fig. 7b and d), in a way reminiscent of control cells that had been transfected with a GFP plasmid alone. No signal was observed along stress fibers, and only some focal contacts were stained to a minor extent. Similar results were obtained when primary chicken fibroblasts rather than COS cells were transfected with the GFP-zyxin constructs, albeit the transfection efficiency was considerably lower in this case (Fig. 7, e-h). Thus, the alpha -actinin binding site is absolutely required for the localization of zyxin to stress fibers (and to some extent also for focal contact localization), whereas the downstream site does not play any obvious role in these experiments.


View larger version (79K):
[in this window]
[in a new window]
 
Fig. 7.   Subcellular distribution of GFP-zyxin fusion proteins. COS cells (a-d) and primary chicken fibroblasts (e-h) were transfected with different zyxin cDNA constructs cloned into a GFP expression vector. One or 2 days after transfection, the cells were prepared for direct fluorescence microscopy. The expression vector contained either wild type zyxin sequence (a and e), zyxin Delta 19-41 (b and f), zyxin Delta 261-283 (c and g), or zyxin Delta 19-41/261-283 (d and h) ligated to the 3'-end of the GFP sequence. Bar, 20 µm.

The alpha -Actinin Binding Site Is Required for Zyxin-dependent alpha -Actinin Recruitment in Living Cells-- To further analyze the alpha -actinin binding activity of zyxin constructs in living cells, we sought to ectopically express different zyxin constructs at discrete subcellular sites. For this, we made use of a mitochondrial targeting system described by Pistor et al. (33). Wild type zyxin and zyxin constructs bearing deletions of either the alpha -actinin binding site (targZyxin Delta 19-41), the related sequence described above (targZyxin Delta 261-283), or both (targZyxin Delta 19-41/Delta 261-283) were cloned into the pSPL61 vector (33, 34), a derivative of the eukaryotic expression vector pMPSVHE (35), for expression as fusion proteins with a 29 amino acid C-terminal peptide. This peptide is derived from the membrane anchor of the L. monocytogenes ActA protein. After transfection into eukaryotic cells, it directs the fusion protein to the mitochondrial surface (33). A major benefit of the mitochondrial targeting system is the absence of any endogenous zyxin and alpha -actinin at these ectopic sites. Therefore, there is no need to discriminate against a background of endogenous proteins. In addition, functionally related proteins are also absent from mitochondria and hence will not interfere with the binding assay.

Transfection of PtK2 cells with these vectors, encoding zyxin fusion proteins under the control of the myeloproliferative sarcoma virus promoter, resulted in high level protein expression, regardless of the construct. Double staining of transfected cells with an antiserum to zyxin and the mitochondrial dye CMTMRos demonstrated that the zyxin fusion proteins almost exclusively colocalized with mitochondria (not shown). Also, independent of the construct used for transfection, mitochondria of transfected cells tended to form extensive clusters (Fig. 8, a-d).


View larger version (121K):
[in this window]
[in a new window]
 
Fig. 8.   Recruitment of alpha -actinin to zyxin constructs targeted to the mitochondrial surface. PtK2 cells were transfected with different zyxin cDNA constructs cloned into a mitochondrial targeting vector. Two days posttransfection, cells were prepared for indirect immunofluorescence microscopy using rabbit anti-zyxin serum AS83-1 (a-d) and mouse anti-alpha -actinin monoclonal antibody BM 75.2 (a'-d'). Primary antibodies were detected with Oregon Green-labeled anti-rabbit and Cy3-labeled anti-mouse antibodies, respectively. The mitochondrial targeting vector contained either wild type zyxin coding sequence (a and a'), zyxin Delta 19-41 (b and b'), zyxin Delta 261-283 (c and c'), or zyxin Delta 19-41/Delta 261-283 (d and d'). Sites of prominent alpha -actinin recruitment to mitochondrial clusters are marked with open arrows (a' and c'). Bar in d (valid for all panels), 20 µm.

Double label indirect immunofluorescence microscopy with antibodies to zyxin and alpha -actinin revealed that wild type zyxin fusion protein was capable of recruiting endogenous alpha -actinin to the mitochondria of transfected cells, a phenomenon that was especially evident at mitochondrial clusters (Fig. 8, a and a'; open arrows). In sharp contrast, a zyxin deletion construct lacking the alpha -actinin binding site (targZyxin Delta 19-41), completely lost its alpha -actinin binding activity (Fig. 8, b and b').

Several binding sites for the focal adhesion and microfilament-associated protein VASP map to a zyxin region starting from about amino acid 69 (25), i.e. in close proximity to the alpha -actinin binding site. Both wild type zyxin and targZyxin Delta 19-41 recruited VASP to the mitochondrial surfaces (not shown). As these closely adjacent VASP binding sites were still functionally preserved, we conclude that the Delta 19-41 deletion did not cause any gross structural disturbance, although we cannot rule out a possible conformational change.

Unlike targZyxin Delta 19-41, deletion of the related sequence element (targZyxin Delta 261-283) did not abolish mitochondrial alpha -actinin recruitment (Fig. 8, c and c'). Finally, constructs bearing deletions of both sites (targZyxin Delta 19-41/Delta 261-283) also failed to direct alpha -actinin to the mitochondria of transfected cells (Fig. 8, d and d'). Obviously, zyxin residues 19-41 are indispensable for alpha -actinin binding not only in blot overlays but also in transfected cells. Moreover, alpha -actinin binding via this site accounts for the major part, if not all, of the alpha -actinin binding activity of zyxin in living cells, as revealed in the mitochondrial targeting assay.

The striking sequence homology between the alpha -actinin binding site and its related downstream sequence raised the question of whether the latter could be rendered a functional alpha -actinin binding site when grafted into the position of the authentic binding site within the polypeptide chain. Therefore, we made a construct, coding for peptide sequence 262-284 inserted into the deletion site of targZyxin Delta 19-41. After transfection of this construct into PtK2 cells, no colocalization of zyxin and alpha -actinin at mitochondria was observed (not shown). This indicates that despite similarities in sequence and charge, the downstream sequence cannot functionally rescue deletion of the alpha -actinin binding site, even if an additional copy is introduced at the normal binding site position.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Using different in vitro and transfection experiments, we have mapped an alpha -actinin binding site in human zyxin. This binding site was found to be both necessary and sufficient for alpha -actinin binding in blot overlay and solid phase binding assays, respectively. The site is also involved in zyxin localization to stress fibers and focal adhesions and is required for alpha -actinin binding to zyxin in a mitochondrial targeting approach, i.e. in the physiological ambience of living cells. In addition, we have shown that the human protein LPP shares a sequence element closely related to the zyxin alpha -actinin binding site, raising the possibility that LPP is also an alpha -actinin-binding protein.

The alpha -Actinin Binding Site of Zyxin Shares Some Features with alpha -Actinin Binding Sites in Proteins That Bind to the alpha -Actinin Central and C-Terminal Region-- Similar to the alpha -actinin binding site of zyxin characterized here (Fig. 5), basic and hydrophobic residues also prevail in several other alpha -actinin binding sites, including those of integrin beta 1 (39, 40), L-selectin (10), and the NR1 subunit of the N-methyl-D-aspartate receptor (11). Integrin beta 1 (6) and L-selectin (10) bind to the 53-kDa thermolysin fragment of alpha -actinin (which comprises both the central and C-terminal regions of the protein). In a yeast two-hybrid assay, the NR1 subunit of the N-methyl-D-aspartate receptor interacts with the region of the central spectrin-like repeats (11). This is remarkable, because zyxin binding has previously been attributed to the N-terminal 27-kDa fragment, not to the 53-kDa fragment of alpha -actinin (18). Apparently, different alpha -actinin domains mediate binding to zyxin and to the other proteins mentioned above. Therefore, we questioned whether the similarities between the alpha -actinin binding sites of zyxin and those other proteins are only fortuitous.

Is There More Than One alpha -Actinin:Zyxin Interface?-- In resolving this issue, it is important to note that the blotted N-terminal 27-kDa proteolytic fragment of alpha -actinin was previously shown to bind radiolabeled full-length zyxin (18). In sharp contrast to these experiments, we used an overlay with radiolabeled alpha -actinin to identify the zyxin region involved in the interaction. Generally, in blot overlays, a labeled native protein is used as probe to detect an interaction with denatured proteins separated by SDS-polyacrylamide gel electrophoresis and blotted to a membrane. Renaturation on the blot membrane should, for example, be easier for small linear peptide motifs than for complex protein folds or complete domains. Therefore it may be unexpected that overlays probing the alpha -actinin-zyxin interaction work in either direction. The existence of two independent binding interfaces may be an obvious explanation. This raises the attractive possibility that native zyxin interacts with a peptide motif in the 27-kDa fragment of alpha -actinin (18), whereas another interaction may be due to binding of a zyxin peptide motif by a different alpha -actinin region (possibly in the central or C-terminal region). In support of this view, both the 27- and 53-kDa alpha -actinin fragments, but not the full-length protein, failed to compete for alpha -actinin binding to zyxin in solid phase binding assays (18). This hypothesis may also explain the similarities between the alpha -actinin binding motifs of zyxin and those of known ligands for the central/C-terminal part of alpha -actinin.

In fact, interaction with more than one alpha -actinin region appears to be quite common and has been suggested for several proteins, such as ICAM-2 (9), actinin-associated LIM protein (41), titin (42), and PKN (12). Vice versa, alpha -actinin ligands often harbor two essentially nonoverlapping, apparently unrelated binding sites in close proximity, as shown for integrin beta 1 (39, 40), Ep-CAM (40), and ICAM-2 (9).

alpha -Actinin Binding Sites: Specific Sequence Requirements or Compositional Bias?-- Besides some bias in amino acid composition, there is no obvious consensus motif for the alpha -actinin binding sites of zyxin (this study), integrin beta 1 (39, 40), L-selectin (10), the NR1 subunit of the N-methyl-D-aspartate receptor (11), and some other alpha -actinin binding sites (8, 9, 40). Indeed, there are reports that even certain scrambled or reverse sequence ICAM-1 and beta 1 integrin peptides show comparable binding activity when tested in vitro (8, 39). Contrary to alpha -actinin binding sites of ICAM-1 and integrin beta 1, our results suggest that the alpha -actinin binding site of zyxin in blot overlays and in transfection experiments is strictly dependent on the sequence of the binding site. In particular, the related sequence element between residues 261 and 283 of human zyxin (Fig. 5) was neither necessary nor sufficient for alpha -actinin binding in blot overlays or in living cells. The negative results obtained with this latter human zyxin peptide are in contrast, however, with overlay experiments performed with synthetic peptides (not shown). 9-21-mer peptides were synthesized in parallel arrays on a solid paper support using the SPOTsTM technology (43). When these peptides were incubated with alpha -actinin, we observed spurious binding to peptides corresponding either to the actual binding site as characterized here or to the nonfunctional downstream element and even to a reverse sequence. This indicates that---in the case of alpha -actinin---binding data based primarily on this type of assay should be interpreted with caution unless confirmed by independent approaches. It will be interesting to investigate whether or not this downstream motif is related to a putative second alpha -actinin binding site that is responsible for alpha -actinin binding in the reciprocal overlay assay. However, the demonstration that chicken zyxin interacts with alpha -actinin in 125I-labeled zyxin overlays (18), although chicken zyxin lacks an element related in sequence to residues 261-283 of human zyxin, argues against such a relationship.

Requirement of the alpha -Actinin-Zyxin Interaction for Proper Subcellular Targeting of Zyxin-- As judged from transfection experiments with GFP-zyxin fusion constructs, the zyxin alpha -actinin interaction appears to be essential for zyxin to adopt the typical dotted pattern of stress fiber localization, because GFP-zyxinDelta 19-41 failed to locate at stress fibers. Nevertheless, interactions of zyxin with proteins other than alpha -actinin appear to recruit the same fusion protein to focal adhesions, although not very efficiently. However, we cannot distinguish whether these differences in subcellular targeting to focal adhesions versus stress fibers reflect true qualitative or only quantitative differences. Zyxin is predominantly concentrated at focal adhesions and the terminal portions of stress fibers, whereas its association with stress fibers proper is characterized by a much finer and weaker staining pattern in indirect immunofluorescence analysis (Fig. 7) (14, 18, 19, 21, 23). Thus, if the deletion of the alpha -actinin binding site would equally impair association with both types of structures, the weaker staining of the fusion protein at stress fibers might be lost, whereas some residual staining of focal adhesions could persist.

GFP-zyxin Delta 19-41 failed to associate with stress fibers. Obviously, the known zyxin interactions with CRPs (14-17) and VASP (23) cannot compensate for direct alpha -actinin binding, although both proteins localize with zyxin along stress fibers and their terminal portions (14, 17, 23, 37). This may be surprising in light of the observation that VASP and zyxin display a virtually indistinguishable subcellular distribution, including a dot-like stress fiber association of identical spacing and periodicity (23) that (at stress fibers) also coincides with alpha -actinin staining (37). In contrast, the indirect immunofluorescence patterns of zyxin and alpha -actinin vastly overlap but are also distinctly different. Specifically, alpha -actinin staining is more pronounced along stress fibers, whereas zyxin is concentrated in the focal adhesions proper (18). However, it has been pointed out that possible differences in antigen accessibility may contribute to these immunofluorescence patterns (3, 18).

Zyxin-dependent alpha -Actinin Recruitment in Living Cells-- Chicken gizzard vinculin, the vinculin head, and the vinculin hinge plus tail domains were very inefficient in recruiting alpha -actinin when tested in the same mitochondrial targeting system as used in this report (34). This is despite the fact that an interaction has been shown in vitro that involves an alpha -actinin binding site in the vinculin head domain (13). These results obtained with mitochondrial targeting of vinculin and vinculin fragments are in sharp contrast to the strong alpha -actinin recruitment observed with a hybrid construct replacing most of the vinculin head by the ActA N-terminal part (amino acids 31-236) (34). Similar alpha -actinin recruitment has been reported for wild type ActA (33, 44). It is still an unresolved issue whether alpha -actinin recruitment by ActA or the ActA-vinculin chimera is due to direct binding or whether alpha -actinin is recruited by the considerable amounts of F-actin that accumulate at the mitochondrial surfaces of cells transfected with these constructs. Like ActA, zyxin is able to recruit F-actin to the mitochondria of transfected cells.3 Nevertheless, in the case of zyxin, we can rule out the possibility that alpha -actinin recruitment is primarily due to an indirect association mediated by F-actin (18) or some other protein(s): a deletion, which is confined to a short zyxin peptide motif that has been positively identified as an alpha -actinin binding site in a parallel in vitro assay, virtually abolishes alpha -actinin recruitment in the targeting assay and alpha -actinin binding to GST-zyxin fusion proteins in blot overlays in vitro.

Regardless of whether the alpha -actinin recruitment by ActA (33, 44) or ActA chimeras (34) turns out to be direct or indirect, the efficient alpha -actinin binding to zyxin and zyxin-dependent F-actin recruitment in living cells lend further support to the view that ActA and zyxin share common functional features.

Similar to the failure of alpha -actinin binding site deletion mutants to localize to stress fibers, the equivalent fusion proteins assayed in the mitochondrial targeting system demonstrated that there was no efficient backup system for recruitment of alpha -actinin to zyxin. In particular, at least in these cells, cysteine-rich protein family members, which bind both zyxin and alpha -actinin (17, 32), do not functionally substitute for the direct alpha -actinin-zyxin interaction.

In conclusion, we have identified and evaluated an alpha -actinin binding site in human zyxin that maps close to the zyxin N terminus and is required for zyxin-dependent alpha -actinin recruitment and proper zyxin localization in living cells. The results presented here have set the stage for investigating the contribution of the alpha -actinin-zyxin interaction in microfilament architecture and regulation.

    ACKNOWLEDGEMENTS

M. R. is grateful to Jürgen Otte and Dietmar von der Ahe (Bad Nauheim, Germany) for sharing human zyxin cDNA prior to publication. We thank Susanne Pistor and Jürgen Wehland (Braunschweig, Germany) for the kind gift of the mitochondrial targeting vector pSPL61 and our colleagues for valuable criticism and comments on the manuscript.

    FOOTNOTES

* This study was supported by Grant 31-50571.97 from the Swiss National Science Foundation, the Bernese Cancer Liga, and the Deutsche Forschungsgemeinschaft.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed. Tel.: 49-931-201-3144; Fax: 49-931-201-3153; E-mail: Matthias.Reinhard{at}mail.uniwuerzburg.de.

2 Krause et al., manuscript in preparation.

3 M. Reinhard and U. Walter, unpublished observations.

    ABBREVIATIONS

The abbreviations used are: ICAM, intercellular adhesion molecule; CRP, cysteine-rich protein; GFP, green fluorescent protein; GST, glutathione S-transferase; LPP, lipoma preferred partner; VASP, vasodilator-stimulated phosphoprotein; PCR, polymerase chain reaction.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
  1. Yamada, K. M., and Geiger, B. (1997) Curr. Opin. Cell Biol. 9, 76-85[CrossRef][Medline] [Order article via Infotrieve]
  2. Schulze, H., Huckriede, A., Noegel, A. A., Schleicher, M., and Jockusch, B. M. (1989) EMBO J. 8, 3587-3593[Abstract]
  3. Pavalko, F. M., Schneider, G., Burridge, K., and Lim, S.-S. (1995) Exp. Cell Res. 217, 534-540[CrossRef][Medline] [Order article via Infotrieve]
  4. Puius, Y. A., Mahoney, N. M., and Almo, S. C. (1998) Curr. Opin. Cell Biol. 10, 23-34[CrossRef][Medline] [Order article via Infotrieve]
  5. Critchley, D. R., and Flood, G. (1999) in Guidebook to the Cytoskeletal and Motor Proteins (Kreis, T., and Vale, R., eds), 2nd Ed., Oxford University Press, San Francisco, in press
  6. Otey, C. A., Pavalko, F. M., and Burridge, K. (1990) J. Cell Biol. 111, 721-729[Abstract]
  7. Pavalko, F. M., and LaRoche, S. M. (1993) J. Immunol. 151, 3795-3807[Abstract/Free Full Text]
  8. Carpén, O., Pallai, P., Staunton, D. E., and Springer, T. A. (1992) J. Cell Biol. 118, 1223-1234[Abstract]
  9. Heiska, L., Kantor, C., Parr, T., Critchley, D. R., Vilja, P., Gahmberg, C. G., and Carpén, O. (1996) J. Biol. Chem. 271, 26214-26219[Abstract/Free Full Text]
  10. Pavalko, F. M., Walker, D. M., Graham, L., Goheen, M., Doerschuk, C. M., and Kansas, G. S. (1995) J. Cell Biol. 129, 1155-1164[Abstract]
  11. Wyszynski, M., Lin, J., Rao, A., Nigh, E., Beggs, A. H., Craig, A. M., and Sheng, M. (1997) Nature 385, 439-442[CrossRef][Medline] [Order article via Infotrieve]
  12. Mukai, H., Toshimori, M., Shibata, H., Takanaga, H., Kitagawa, M., Miyahara, M., Shimakawa, M., and Ono, Y. (1997) J. Biol. Chem. 272, 4740-4746[Abstract/Free Full Text]
  13. Kroemker, M., Rüdiger, A.-H., Jockusch, B. M., and Rüdiger, M. (1994) FEBS Lett. 355, 259-262[CrossRef][Medline] [Order article via Infotrieve]
  14. Sadler, I., Crawford, A. W., Michelsen, J. W., and Beckerle, M. C. (1992) J. Cell Biol. 119, 1573-1587[Abstract]
  15. Schmeichel, K. L., and Beckerle, M. C. (1994) Cell 79, 211-219[Medline] [Order article via Infotrieve]
  16. Schmeichel, K. L., and Beckerle, M. C. (1998) Biochem. J. 331, 885-892[Medline] [Order article via Infotrieve]
  17. Louis, H. A., Pino, J. D., Schmeichel, K. L., Pomiès, P., and Beckerle, M. C. (1997) J. Biol. Chem. 272, 27484-27491[Abstract/Free Full Text]
  18. Crawford, A. W., Michelsen, J. W., and Beckerle, M. C. (1992) J. Cell Biol. 116, 1381-1393[Abstract]
  19. Crawford, A. W., and Beckerle, M. C. (1991) J. Biol. Chem. 266, 5847-5853[Abstract/Free Full Text]
  20. Zumbrunn, J., and Trueb, B. (1996) Eur. J. Biochem. 241, 657-663[Abstract]
  21. Macalma, T., Otte, J., Hensler, M. E., Bockholt, S. M., Louis, H. A., Kalff-Suske, M., Grzeschik, K.-H., von der Ahe, D., and Beckerle, M. C. (1996) J. Biol. Chem. 271, 31470-31478[Abstract/Free Full Text]
  22. Petit, M. M. R., Mols, R., Schoenmakers, E. F. P. M., Mandahl, N., and Van De Ven, W. J. M. (1996) Genomics 36, 118-129[CrossRef][Medline] [Order article via Infotrieve]
  23. Reinhard, M., Jouvenal, K., Tripier, D., and Walter, U. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 7956-7960[Abstract]
  24. Gertler, F. B., Niebuhr, K., Reinhard, M., Wehland, J., and Soriano, P. (1996) Cell 87, 227-239[Medline] [Order article via Infotrieve]
  25. Niebuhr, K., Ebel, F., Frank, R., Reinhard, M., Domann, E., Carl, U. D., Walter, U., Gertler, F., Wehland, J., and Chakraborty, T. (1997) EMBO J. 16, 5433-5444[Abstract/Free Full Text]
  26. Hobert, O., Schilling, J. W., Beckerle, M. C., Ullrich, A., and Jallal, B. (1996) Oncogene 12, 1577-1581[Medline] [Order article via Infotrieve]
  27. Chakraborty, T., Ebel, F., Domann, E., Niebuhr, K., Gerstel, B., Pistor, S., Temm-Grove, C. J., Jockusch, B. M., Reinhard, M., Walter, U., and Wehland, J. (1995) EMBO J. 14, 1314-1321[Abstract]
  28. Golsteyn, R. M., Beckerle, M. C., Koay, T., and Friederich, E. (1997) J. Cell Sci. 110, 1893-1906[Abstract/Free Full Text]
  29. Dramsi, S., and Cossart, P. (1998) Annu. Rev. Cell Dev. Biol. 14, 137-166[CrossRef][Medline] [Order article via Infotrieve]
  30. Zigmond, S. H. (1998) Curr. Biol. 8, R654-R657[Medline] [Order article via Infotrieve]
  31. Reinhard, M., Giehl, K., Abel, K., Haffner, C., Jarchau, T., Hoppe, V., Jockusch, B. M., and Walter, U. (1995) EMBO J. 14, 1583-1589[Abstract]
  32. Pomiès, P., Louis, H. A., and Beckerle, M. C. (1997) J. Cell Biol. 139, 157-168[Abstract/Free Full Text]
  33. Pistor, S., Chakraborty, T., Niebuhr, K., Domann, E., and Wehland, J. (1994) EMBO J. 13, 758-763[Abstract]
  34. Bubeck, P., Pistor, S., Wehland, J., and Jockusch, B. M. (1997) J. Cell Sci. 110, 1361-1371[Abstract/Free Full Text]
  35. Artelt, P., Morelle, C., Ausmeier, M., Fitzek, M., and Hauser, H. (1988) Gene 68, 213-219[CrossRef][Medline] [Order article via Infotrieve]
  36. Koller, E., Hayman, A. R., and Trueb, B. (1991) Nucleic Acids Res. 19, 485-491[Abstract]
  37. Reinhard, M., Halbrügge, M., Scheer, U., Wiegand, C., Jockusch, B. M., and Walter, U. (1992) EMBO J. 11, 2063-2070[Abstract]
  38. Feramisco, J. R., and Burridge, K. (1980) J. Biol. Chem. 255, 1194-1199[Abstract/Free Full Text]
  39. Otey, C. A., Vasquez, G. B., Burridge, K., and Erickson, B. W. (1993) J. Biol. Chem. 268, 21193-21197[Abstract/Free Full Text]
  40. Balzar, M., Bakker, H. A. M., Briaire-De-Bruijn, I. H., Fleuren, G. J., Warnaar, S. O., and Litvinov, S. V. (1998) Mol. Cell. Biol. 18, 4833-4843[Abstract/Free Full Text]
  41. Xia, H., Winokur, S. T., Kuo, W.-L., Altherr, M. R., and Bredt, D. S. (1997) J. Cell Biol. 139, 507-515[Abstract/Free Full Text]
  42. Young, P., Ferguson, C., Bañuelos, S., and Gautel, M. (1998) EMBO J. 17, 1614-1624[Abstract/Free Full Text]
  43. Frank, R. (1992) Tetrahedron 48, 9217-9232[CrossRef]
  44. Pistor, S., Chakraborty, T., Walter, U., and Wehland, J. (1995) Curr. Biol. 5, 517-525[Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.